Real-World Evidence and Treatment Patterns: Head and Neck Cancer

Nimotuzumab Combined With Neoadjuvant Chemotherapy in the Treatment of Resectable LA HNSCC

NCT05351762 ·Status: UNKNOWN ·Phase: PHASE2

Efficacy and Safety of PD-1 Plus Chemotherapy in Poorly Differentiated Locally Advanced (LA) HNSCC

NCT06100497 ·Status: RECRUITING ·Phase: PHASE2

Trial of Nivolumab vs Therapy of Investigator's Choice in Recurrent or Metastatic Head and Neck Carcinoma (CheckMate 141)

NCT02105636 ·Status: COMPLETED ·Phase: PHASE3

Study Evaluating a Stereotactic Boost/Treatment for Recurrent or Metastatic Cancer of the Head and Neck

NCT02474368 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1

A Study of Nivolumab in Patients With Head and Neck Cancer.

NCT04050761 ·Status: COMPLETED

Nasopharyngeal Carcinoma Treated With Reduced Volume Intensity Modulated Radiation Therapy:10-Year Outcome and Late Toxicity, Quality of Life

NCT06136962 ·Status: NOT_YET_RECRUITING

Study to Evaluate the Safety and Efficacy of Oral NRC-2694-A in Combination With Paclitaxel in Patients With Recurrent and/or Metastatic Head and Neck Squamous Cell Carcinoma, Who Progressed on or After Immune Checkpoint Inhibitor Therapy

NCT05283226 ·Status: RECRUITING ·Phase: PHASE2

Research of Biomarkers of Activity and Efficacy of BIBW2992 in Untreated Non-metastatic HNSCC Patients

NCT01415674 ·Status: COMPLETED ·Phase: PHASE2

A Prospective Randomized Trial of Capecitabine Treatment in Patients With HNSCC

NCT03678649 ·Status: UNKNOWN ·Phase: PHASE2

Definitive Chemo-Radiotherapy for Regionally Advanced Head and Neck Cancer With or Without Up-front Neck Dissection

NCT02918955 ·Status: COMPLETED ·Phase: PHASE3

Sufficient Chemotherapy Combine With Maintenance Chemotherapy in the Treatment of Oligometastatic Nasopharyngeal Carcinoma

NCT04319471 ·Status: UNKNOWN ·Phase: PHASE2

A Study of Pembrolizumab (MK-3475) for First Line Treatment of Recurrent or Metastatic Squamous Cell Cancer of the Head and Neck (MK-3475-048/KEYNOTE-048)

NCT02358031 ·Status: COMPLETED ·Phase: PHASE3

A Study of Treatment Patterns and Clinical Outcomes in First Line Recurrent/Metastatic Squamous Cell Carcinoma of the Head and Neck (1L R/M SCCHN) Participants in Europe

NCT05123950 ·Status: COMPLETED

Late Phase II Study of Weekly Paclitaxel (BMS-181339) in Patients With Advanced or Recurrent Head and Neck Cancer

NCT00855764 ·Status: COMPLETED ·Phase: PHASE2

Safety and Efficacy of SCT-I10A in Head and Neck Squamous Cell Carcinoma

NCT04146181 ·Status: UNKNOWN ·Phase: PHASE2

Molecular-Based Selection of Patients with Head and Neck Squamous Cell Carcinoma: Biomarker Analysis

NCT06905145 ·Status: RECRUITING

Study of Nivolumab in Combination With Ipilimumab Compared to the Standard of Care (Extreme Regimen) as First Line Treatment in Patients With Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck

NCT02741570 ·Status: COMPLETED ·Phase: PHASE3

Phase II Trial of Carboplatin, 5-FU and Cetuximab in Elderly Fit (no Frailty) Patients With Recurrent/Metastatic HNSCC

NCT01864772 ·Status: COMPLETED ·Phase: PHASE2

Multicentric Comparative Study Between a Conventional and an Intensive Follow up Strategy After Treatment of a Head and Neck Squamous Cell Carcinoma

NCT03519048 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3

Prognostic Immune Biomarkers in HNSCC

NCT05941676 ·Status: COMPLETED

A Phase II Study to Evaluate the Efficacy and Safety of Salvage Preoperative PD-1 Inhibitor Combined with Chemotherapy Neoadjuvant Therapy in Recurrent and Metastatic LPSCC/HPSCC

NCT06793761 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2

Study on the Efficacy of Treatment by Radiotherapy and Pembrolizumab in Newly Diagnosed Metastatic Head & Neck Cancers

NCT04747054 ·Status: RECRUITING ·Phase: PHASE3

A Study of Decreasing Radiation Therapy and Chemotherapy in People With Head and Neck Cancer

NCT05544136 ·Status: RECRUITING ·Phase: PHASE2

A Phase Ⅱ/Ⅲ Study of Rulonilimab Plus Chemotherapy± Bevacizumab for the First-Line Treatment of Persistent, Recurrent or Metastatic Cervical Cancer

NCT06755515 ·Status: ENROLLING_BY_INVITATION ·Phase: PHASE2/PHASE3

Optimization of Cervical Nodal CTV for Early and Medium Stage NPC

NCT05145660 ·Status: RECRUITING ·Phase: PHASE3